Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

Recursion Pharmaceuticals将于周三美股开盘前公布2025年第四季度及全年业绩,投资者密切关注这家AI驱动的生物科技公司能否将其庞大的数据平台转化为持续的收入增长和临床成功。 分析师预计该公司每股亏损30美分,营收为2450万美元,较第三季度每股亏损36美分、营收仅520万美元有大幅改善。营收近五倍的增长将成为Recursion商业模式的关键验证点,该模式依赖于与罗氏、拜耳和 ...

英为财情Investing.com - Recursion Pharmaceuticals (NASDAQ: RXRX )星期三发布了第四季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。

Recursion is hosting about 60 investors and analysts at its headquarters in Utah. It has generated tons of data with AI and robots, aiming to find a better way to make drugs. Recursion, which has four ...

Recursion Pharmaceuticals leverages AI and machine learning to revolutionize drug discovery, reducing costs and accelerating development, positioning itself as a leader in tech-driven biopharma. The ...

Recursion Pharmaceuticals presents a compelling investment opportunity due to its AI-driven drug discovery platform, solid financials, and diverse pipeline, setting it apart from competitors like ...

Shares of Recursion Pharmaceuticals are down by about 47% from a peak the stock set this February. The company uses automation and artificial intelligence to optimize the new drug-discovery process.

On sci-fi TV shows like Star Trek, when a doctor needs to cure a disease, they often ask the computer to simulate complex visualizations or go through databases for potential cures. In real life, ...

Salt Lake City, UT, July 08, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of ...

Success for just one of Recursion's phase 2 programs could enable the stock to double within five years. However, the odds of success for phase 2 candidates aren't good. Risk-averse investors should ...

Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and making regular contributions to a retirement account, allowing the ...